You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine Carcinomas

Showing 1 - 25 of 1,268
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Neuroendocrine Carcinomas
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

Carcinomas, Cervix Cancer, Cervical Cancer Trial in Houston (AK104)

Recruiting
  • Carcinomas
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

High Grade Malignant Neuroendocrine Carcinoma (Diagnosis) Trial in San Francisco, Boston, New York (Pembrolizumab, Irinotecan,

Completed
Has Results
  • High Grade Malignant Neuroendocrine Carcinoma (Diagnosis)
  • San Francisco, California
  • +2 more
Dec 5, 2022

Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Trial in Cleveland (TQ Formula (black

Not yet recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Gastroenteropancreatic Neuroendocrine Neoplasm
  • TQ Formula (black seed oil capsules)
  • +2 more
  • Cleveland, Ohio
    University hospitals Seidman Cancer Center, Case Comprehensive C
Aug 12, 2022

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

Recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • Chiba, Japan
  • +1 more
Jan 16, 2023

Epiction of Genomic and Genetic Landscape Identifies CCL5

Completed
  • Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5
    • (no location specified)
    Jan 27, 2023

    Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)

    Recruiting
    • Neuroendocrine Tumours (NET)
    • Neuroendocrine Carcinomas (NEC)
    • Santiago De Compostela, Galicia, Spain
    • +4 more
    Aug 1, 2022

    Neuroendocrine Tumors Trial (BI 764532, Carboplatin, Etoposide)

    Not yet recruiting
    • Neuroendocrine Neoplasms
    • BI 764532
    • +3 more
    • (no location specified)
    Nov 10, 2023

    Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)

    Not yet recruiting
    • Small Cell Lung Carcinoma
    • Neuroendocrine Neoplasms
    • BI 764532
    • (no location specified)
    May 22, 2023

    Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

    Not yet recruiting
    • Small-cell Lung Cancer
    • Neuroendocrine Carcinoma
    • (no location specified)
    Jun 13, 2022

    Advanced or Metastatic EP-NEC Trial in Wuhan (Camrelizumab, Etoposide, Carboplatin)

    Not yet recruiting
    • Advanced or Metastatic EP-NEC
    • Wuhan, Hubei, China
      Tongji Hospital，Tongji Medical College Affiliated，Huazhong Unive
    Nov 22, 2021

    Cancer Trial in Germany (Avelumab)

    Completed
    • Cancer
    • Halle (Saale), Germany
    • +3 more
    Feb 24, 2022

    Neuroendocrine Tumors, Carcinoid Tumors Trial in Stanford, Tampa (Pasireotide Long Acting Release (LAR))

    Active, not recruiting
    Has Results
    • Neuroendocrine Tumors
    • Carcinoid Tumors
    • Pasireotide Long Acting Release (LAR)
    • Stanford, California
    • +1 more
    Jan 11, 2022

    Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

    Not yet recruiting
    • Carcinoid Tumor Lung
    • +2 more
    • 212-Lead Pentixather
    • 203-Lead Pentixather SPECT/CT
    • Iowa City, Iowa
      The University of Iowa Theranostics Center
    Sep 23, 2022

    Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

    Recruiting
    • Microsatellite High Cancers
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 8, 2022

    Pancreatic Neuroendocrine Tumors and Carcinomas

    Recruiting
    • Cancer of Pancreas
      • Strasbourg, France
        Service d'Oncologie - CHU de Strasbourg - France
      Jan 31, 2022

      Lung Small Cell Carcinoma, Neuroendocrine Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Dostarlimab, Niraparib)

      Recruiting
      • Lung Small Cell Carcinoma
      • +5 more
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 30, 2021

      Neuroendocrine Carcinomas Trial in Amsterdam, Groningen, Rotterdam (cisplatinum and everolimus)

      Active, not recruiting
      • Neuroendocrine Carcinomas
      • cisplatinum and everolimus
      • Amsterdam, Netherlands
      • +2 more
      Apr 19, 2021

      Neuroendocrine Carcinoma, Digestive Cancer Trial in France (Neoadjuvant treatment, Adjuvant treatment)

      Recruiting
      • Neuroendocrine Carcinoma
      • Digestive Cancer
      • Neoadjuvant treatment
      • Adjuvant treatment
      • Amiens, France
      • +13 more
      Jun 10, 2021

      Neuroendocrine Carcinomas Trial in Napoli (Temozolomide)

      Completed
      • Neuroendocrine Carcinomas
      • Napoli, Campania, Italy
        Istituto Tumori di Napoli - Fondazione G. Pascale
      Oct 22, 2020

      Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Carcinoma Trial in United States (Lurbinectedin)

      Recruiting
      • Advanced Solid Tumor
      • +4 more
      • Stanford, California
      • +15 more
      Dec 21, 2022

      Chemo, Anti-pd-1 Antibody, Cervical Neuroendocrine Carcinoma Trial in Beijing (Drug therapy)

      Recruiting
      • Chemotherapy
      • +6 more
      • Drug therapy
      • Beijing, Beijing, China
        Lei Li
      Nov 15, 2020

      Metastatic Large Cell Neuroendocrine Carcinoma, Metastatic Neuroendocrine Carcinoma, Metastatic Neuroendocrine Tumor Trial in

      Active, not recruiting
      • Metastatic Large Cell Neuroendocrine Carcinoma
      • +3 more
      • Cabozantinib S-malate
      • +2 more
      • Birmingham, Alabama
      • +46 more
      Dec 30, 2022

      Neuroendocrine Carcinoma Trial in Italy (CPT-11, Calcio levofolinate, 5-Fluorouracil)

      Recruiting
      • Neuroendocrine Carcinoma
      • Ancona, AN, Italy
      • +22 more
      Feb 25, 2021

      Neuroendocrine Carcinomas Trial in France (Folfiri-bevacizumab, Folfiri)

      Recruiting
      • Neuroendocrine Carcinomas
      • Amiens, France
      • +26 more
      Jan 26, 2022